Association of Survival With Femoropopliteal Artery Revascularization With Drug-Coated Devices.

ABSTRACT:

Importance

In a recent meta-analysis of randomized clinical trials, femoropopliteal artery revascularization with paclitaxel drug-coated devices was associated with increased long-term all-cause mortality compared with non-drug-coated devices. However, to our knowledge, these findings have not been replicated in other data sources and may be subject to confounding from missing data associated with patient withdrawal and loss to follow-up.

Objective

To evaluate differences in all-cause mortality between patients who were treated with drug-coated devices vs non-drug-coated devices for femoropopliteal artery revascularization.

Design, setting, and participants

This nationwide, multicenter retrospective cohort study included 16 560 Centers for Medicare and Medicaid Servic

SUBMITTER: Secemsky EA 

PROVIDER: S-EPMC6484791 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature